Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis

Cancer Research

Volumn 67, Issue 7, 2007, Pages 3263-3268

  Murata, Kazumoto ^a   Moriyama, Masami ^b  

^a MIE UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; ESSENTIAL AMINO ACID; HYPOXIA INDUCIBLE FACTOR 1; ISOLEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; MESSENGER RNA; PROTEIN KINASE; VASCULOTROPIN A;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER PREVENTION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG SAFETY; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INNATE IMMUNITY; LIVER METASTASIS; MALE; MEMORY T LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOLOGY; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; COLONIC NEOPLASMS; ISOLEUCINE; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN KINASES; RNA, MESSENGER; SPLEEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34248147409     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3739     Document Type: Article

References (31)

1. Simmonds PC; Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systemic review and meta-analysis. BMJ 2000; 321:531-5.
2. Sargent DJ, Niedzwiecki D, O'Connell MJ, Schilsky RL. Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Eng J Med 2001;345:144-5.
3. Delaunoit T, Goldberg RM, Sargent DJ, et al. Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741. Cancer 2004;101:2170-6.
4. de Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol 1997;15:808-15.
5. Levi F, Zidani R, Misset JL; International Organization for Cancer Chronotherapy. Randomized multicentre trial of chronotherapy with oxliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997; 350:681-6.
6. Schonwetter BS, Stolzenberg ED, Zasloff MA. Epithelial antibiotics induced at sites of inflammation. Science 1995;267:1645-8.
7. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol 1986;60: 1068-74.
8. Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilsor JM. Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;21:553-60.
9. Wilson CL, Ouellette AJ, Satchell DP, et al. Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 1999;286: 113-7.
10. Yang D, Chertov O, Bykovskaia SN, et al. β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-8.
11. Chertov O, Yang D, Howard OMZ, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000;177:68-78.
12. Biragyn A, Surenhu M, Yang D, et al. Mediators of innate that target immature, but mature, dendritic cells induce antitumor immunity when generally fused with nonimmunogenic tumor antigen. J Immunol 2001;167: 6644-53.
13. Russell JP, Diamond G, Tarver AP, Scanlin TF, Bevins CL. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor α. Infect Immun 1996;64:1565-8.
14. Mathews M, Jia HP, Guthmiller JM, et al. Production of β-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999;67:2740-5.
15. Fehlbaum P, Rao M, Zasloff M, Anderson GM. An essential amino acid induces epithelial β-defensin expression. Proc Natl Acad Sci U S A 2000;7:12723-8.
16. Folkman J. Tumor angiogenesis: therapeutic implications. N Eng J Med 1971;285:1182-6.
17. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
18. Holmgren L, O'Reilly MS, Folkman J. Dormacy of micro metastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:149-53.
19. De Benedetti A, Harris AL. eIF-4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 1999;31:59-72.
20. Raught B, Gingras AC. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol 1999;31:43-57.
21. 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 2002;158:165-74.
22. Guba M, Breitenbuch PV, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002;8:128-35.
23. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 2000;130:2413-9.
24. Ijichi C, Matsumura T, Tsuji T, Eto Y. Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem Biophys Res Commun 2003;303:59-64.
25. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000;192:921-30.
26. Bals R, Wang X, Meegalla RL, et al. Mouse β-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun 1999;67: 3542-7.
27. Kimura M, Ogihara M. Effects of branched-chain amino acids on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Eur J Pharmacol 2005;510:167-80.
28. Jiang BH, Zheng JZ, Aoki M, Vogt PK. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 2000;97: 1749-53.
29. Zhong H, Chiles K, Feldser D, et al. Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/ AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000;60:1541-5.
30. Zundel W, et al. Loss of PTEN facilities HIF-1-mediated gene expression. Genes Dev 2000;14:391-6.
31. Pore N, Liu S, Shu HK, et al. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 2004;15: 4841-53.